Search Results - "Robaa, Dina"
-
1
The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
Published in Medicinal research reviews (01-01-2018)“…Sirtuins are NAD+‐dependent protein deacylases that cleave off acetyl, as well as other acyl groups, from the ε‐amino group of lysines in histones and other…”
Get full text
Journal Article -
2
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
Published in Journal of medicinal chemistry (25-01-2018)“…Here we report the development of a proteolysis targeting chimera (PROTAC) based on the combination of the unique features of the sirtuin rearranging ligands…”
Get full text
Journal Article -
3
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Published in International journal of molecular sciences (01-01-2024)“…HDAC11 is a class IV histone deacylase with no crystal structure reported so far. The catalytic domain of HDAC11 shares low sequence identity with other HDAC…”
Get full text
Journal Article -
4
Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells
Published in eLife (27-11-2018)“…Cytokines and chemokines are produced and secreted by a broad range of immune cells including macrophages. Remarkably, little is known about how these…”
Get full text
Journal Article -
5
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
Published in Journal of medicinal chemistry (25-02-2016)“…The reversible acetylation of lysines is one of the best characterized epigenetic modifications. Its involvement in many key physiological and pathological…”
Get full text
Journal Article -
6
Exploring aromatic cage flexibility of the histone methyllysine reader protein Spindlin1 and its impact on binding mode prediction: an in silico study
Published in Journal of computer-aided molecular design (01-06-2021)“…Some of the main challenges faced in drug discovery are pocket flexibility and binding mode prediction. In this work, we explored the aromatic cage flexibility…”
Get full text
Journal Article -
7
Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features
Published in International journal of molecular sciences (03-01-2017)“…CPT (carnitine palmitoyltransferase) II muscle deficiency is the most common form of muscle fatty acid metabolism disorders. In contrast to carnitine…”
Get full text
Journal Article -
8
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants
Published in Journal of medicinal chemistry (21-11-2018)“…Metal-dependent histone deacetylases (HDACs) are key epigenetic regulators that represent promising therapeutic targets for the treatment of numerous human…”
Get full text
Journal Article -
9
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors
Published in Journal of medicinal chemistry (14-02-2019)“…The phenothiazine system was identified as a favorable cap group for potent and selective histone deacetylase 6 (HDAC6) inhibitors. Here, we report the…”
Get full text
Journal Article -
10
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
Published in Journal of medicinal chemistry (24-03-2016)“…Schistosomiasis is a major neglected parasitic disease that affects more than 265 million people worldwide and for which the control strategy consists of mass…”
Get full text
Journal Article -
11
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
Published in International journal of molecular sciences (07-07-2022)“…In addition to involvement in epigenetic gene regulation, histone deacetylases (HDACs) regulate multiple cellular processes through mediating the activity of…”
Get full text
Journal Article -
12
Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 ( sm HDAC8) Inhibitors
Published in Molecules (Basel, Switzerland) (28-04-2021)“…Histone-modifying proteins have been identified as promising targets to treat several diseases including cancer and parasitic ailments. methods have been…”
Get full text
Journal Article -
13
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
Published in Pharmaceuticals (Basel, Switzerland) (10-01-2022)“…Schistosomiasis is a major neglected parasitic disease that affects more than 240 million people worldwide and for which the control strategy consists of mass…”
Get full text
Journal Article -
14
Mind the Methyl: Methyllysine Binding Proteins in Epigenetic Regulation
Published in ChemMedChem (01-03-2014)“…Epigenetics is defined as the phenomenon of heritable phenotypic traits that are not governed by alteration of the genetic code. Major epigenetic control…”
Get full text
Journal Article -
15
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
Published in International journal of molecular sciences (29-12-2021)“…Class I histone deacetylases (HDACs) are key regulators of cell proliferation and they are frequently dysregulated in cancer cells. We report here the…”
Get full text
Journal Article -
16
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds
Published in Pharmaceuticals (Basel, Switzerland) (01-07-2023)“…Histone deacetylases (HDAC) represent promising epigenetic targets for several diseases including different cancer types. The HDAC inhibitors approved to date…”
Get full text
Journal Article -
17
Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors
Published in Molecules (Basel, Switzerland) (14-04-2022)“…Class I histone deacetylases, HDAC1, HDAC2, and HDAC3, represent potential targets for cancer treatment. However, the development of isoform-selective drugs…”
Get full text
Journal Article -
18
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation
Published in European journal of medicinal chemistry (20-01-2018)“…FAD-dependent lysine-specific demethylase 1 (LSD1) is overexpressed or deregulated in many cancers such as AML and prostate cancer and hence is a promising…”
Get full text
Journal Article -
19
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
Published in Molecules (Basel, Switzerland) (02-03-2018)“…A promising means in the search of new small molecules for the treatment of schistosomiasis (amongst other parasitic ailments) is by targeting the parasitic…”
Get full text
Journal Article -
20
Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 Inhibitors
Published in International journal of molecular sciences (31-05-2021)“…The chromatin reader protein Spindlin1 plays an important role in epigenetic regulation, through which it has been linked to several types of malignant tumors…”
Get full text
Journal Article